's stock had its "sell (d)" rating restated by research analysts at
Weiss Ratings in a report issued on Wednesday,
Weiss Ratings reports.
OraSure Technologies Trading Up 2.5%
OSUR opened at $3.24 on Wednesday. OraSure Technologies has a 12-month low of $2.36 and a 12-month high of $4.60. The business's fifty day simple moving average is $3.13 and its 200-day simple moving average is $3.04. The company has a market capitalization of $236.97 million, a price-to-earnings ratio of -4.84 and a beta of 0.46.
Institutional Investors Weigh In On OraSure Technologies
A number of institutional investors have recently added to or reduced their stakes in OSUR. Private Management Group Inc. bought a new stake in OraSure Technologies during the first quarter valued at about $14,886,000. Gagnon Securities LLC acquired a new stake in OraSure Technologies in the first quarter worth about $3,619,000. Gagnon Advisors LLC acquired a new stake in OraSure Technologies in the first quarter worth about $2,687,000. Systematic Financial Management LP boosted its holdings in OraSure Technologies by 35.3% in the second quarter. Systematic Financial Management LP now owns 2,229,076 shares of the medical instruments supplier's stock worth $6,687,000 after acquiring an additional 581,926 shares in the last quarter. Finally, Cannell Capital LLC boosted its holdings in OraSure Technologies by 33.7% in the second quarter. Cannell Capital LLC now owns 1,864,989 shares of the medical instruments supplier's stock worth $5,595,000 after acquiring an additional 470,536 shares in the last quarter. Institutional investors own 93.50% of the company's stock.
OraSure Technologies Company Profile
(
Get Free Report)
OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider OraSure Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and OraSure Technologies wasn't on the list.
While OraSure Technologies currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
